Skip to main content
PMC home page
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1966 Jan;26(1):212–217. doi: 10.1111/j.1476-5381.1966.tb01823.x

Absorption, metabolism and excretion of di(rho-aminophenyl) sulphone (dapsone) and di(rho-aminophenyl) sulphoxide in man.

G A Ellard
PMCID: PMC1510771  PMID: 5919504

Full text

PDF
215

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOYER F., TROESTLER J., RIST N., TABONE J. Recherches sur le mode d'activité des sulfones; II.--Etude analytique. Ann Inst Pasteur (Paris) 1950 Jan;78(1):140–143. [PubMed] [Google Scholar]
  2. BUSHBY S. R. The chemotherapy of leprosy. Pharmacol Rev. 1958 Mar;10(1):1–42. [PubMed] [Google Scholar]
  3. BUSHBY S. R., WOIWOD A. J. Excretion products of 4:4'-diaminodiphenyl sulfone. Am Rev Tuberc. 1955 Jul;72(1):123–125. doi: 10.1164/artpd.1955.72.1.123. [DOI] [PubMed] [Google Scholar]
  4. BUSHBY S. R., WOIWOD A. J. The identification of the major diazotizable metabolite of 4:4'-diaminodiphenyl sulphone in rabbit urine. Biochem J. 1956 Jul;63(3):406–408. doi: 10.1042/bj0630406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. BUU-HOI N. P., NGUYEN-BA-KHUYEN, NGUYEN-DAT-XUONG Six mois de chimiothérapie antilépreuse au Sud-Vietnam avec le 4,4'-diaminodiphénylsulfoxyde et le 4,4'-diéthoxythiocarbanilide. Bull Acad Natl Med. 1955 May 3;139(15-16):275–280. [PubMed] [Google Scholar]
  6. Buttle G. A., Dewing T., Foster G. E., Gray W. H., Smith S., Stephenson D. The action of substances allied to 4:4'-diaminodiphenylsulphone in streptococcal and other infections in mice. Biochem J. 1938 Jul;32(7):1101–1110. doi: 10.1042/bj0321101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. CHATTERJEE K. R., PODDAR R. K. Radioactive tracer studies on uptake of di-amino-diphenyl-sulphone by leprosy patients. Proc Soc Exp Biol Med. 1957 Jan;94(1):122–125. doi: 10.3181/00379727-94-22875. [DOI] [PubMed] [Google Scholar]
  8. DAVEY T. F. Experience with "avlosulfon" soluble. Lepr Rev. 1956 Jan;27(1):6–18. doi: 10.5935/0305-7518.19560003. [DOI] [PubMed] [Google Scholar]
  9. DAVEY T. F., KISSAUN A. M., MONETA G. The treatment of leprosy with diaminodiphenyl sulphoxide: a progress report. Lepr Rev. 1957 Apr;28(2):51–59. doi: 10.5935/0305-7518.19570006. [DOI] [PubMed] [Google Scholar]
  10. LAVIRON P., LAURET L., KERBASTARD P., JARDIN C. Le 4, 4'-diaminodiphénylsulfoxyde dans le traitement de la lèpre. Bull Acad Natl Med. 1957 Mar 5;141(9-10):195–204. [PubMed] [Google Scholar]
  11. LEVI A. A., SNOW G. A. Metabolism and excretion of di(p-aminophenyl) sulphoxide in different animal species. Br J Pharmacol Chemother. 1960 Mar;15:160–164. doi: 10.1111/j.1476-5381.1960.tb01225.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. LOWE J. Studies in sulphone therapy. Lepr Rev. 1952 Jan;23(1):4–29. doi: 10.5935/0305-7518.19520002. [DOI] [PubMed] [Google Scholar]
  13. TITUS E., BERNSTEIN J. The pharmacology of the sulfones. Ann N Y Acad Sci. 1949 Dec 14;52(5):719–728. doi: 10.1111/j.1749-6632.1949.tb53962.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES